NextPlat shares fell 15.3% after the earnings release, with the transcript pointing to ongoing pressure in retail pharmacy revenue and a sequential $0.3 million decline in medication-fulfillment contracts after a customer closed a facility. Management also delayed the healthcare e-commerce launch to this month, tempering the turnaround narrative despite year-over-year improvement in margins and operating losses.
- Contracted pharmacy revenue was nearly 300% higher year over year, but one customer’s facility closure reduced medication-fulfillment revenue by about $0.3 million sequentially.
- Total pharmacy prescription revenue declined year over year, reflecting lower payer reimbursement rates, fewer prescriptions, and payer mix.
- NextPlat added three 340B contracts in the quarter, bringing the annual total to 14; management said onboarding typically takes around 90 days.
- The Scott’s Pharmacy acquisition is expected to contribute about $1.2 million in quarterly revenue and $150,000 in net profit during Q4, based on current activity.
- The healthcare e-commerce site launch slipped from the expected Q3 timing and is now expected this month.
Community Discussion